Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 5387 of 6351
-
Shorter blood thinner course after birth may be just as safe
Disease control CompletedThis is single centre pilot, randomized controlled trial assessing postpartum prophylactic anticoagulation with 3 weeks of LMWH followed by 3 weeks of Aspirin compared to standard of care of prophylactic LMWH for 6 weeks at moderate to high risk of developing VTE.
Sponsor: Mount Sinai Hospital, Canada • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
App aids ICU families in tough choices
Knowledge-focused CompletedBy developing a smart mobile shared decision-making (SDM) model, this study aims to assist family members of critically ill end-stage patients in making appropriate decisions, enhance their decision quality, and evaluate the model's effectiveness
Sponsor: CHIA-HUI MA • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Taiwan study hunts for hidden genetic clues in rare stomach cancer
Knowledge-focused OngoingThe genetic background for cancer treatment may also be different among different areas and races. There is lack of Taiwanese data of genetic alterations in cancer patients. To understand the landscape of genetic aberrations of cancer in Taiwan, large scale survey of the cancer p…
Sponsor: National Health Research Institutes, Taiwan • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Lung cancer immunotherapy duration study halted early
Knowledge-focused Stopped earlyNon-comparative multicentric randomized study to assess long-term benefit of PD-1 inhibition in NSCLC patients who experienced a response between 6 and 12 months after initiation of ICI (immune checkpoint inhibitor PD1/PDL-1 blockade therapy)
Phase 2 • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Knee OA drug combo trial ends early — only 23 enrolled
Symptom relief Stopped earlyThe study was established to show safety and efficacy of canakinumab and LNA043 in patients with knee osteoarthritis (OA).
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Can a smartphone app help people with asthma breathe easier?
Disease control CompletedThe long-term goal is to improve the care of patients with asthma. The overarching objective of this pilot grant is to test the feasibility, acceptability and potential clinical utility of deploying a mobile-health intervention to improve asthma surveillance.
Sponsor: Linnea Polgreen • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Can a simple exercise test predict heart risks in breast cancer patients?
Knowledge-focused OngoingThe purpose of this study is to find out how much oxygen is used during a cardiopulmonary exercise test (CPET) in women who have mild cardiotoxicity after standard treatment for HER2-positive breast cancer, and to see whether the results of this test can be used to predict how we…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Surgical tactic may cut hiatal hernia recurrence
Knowledge-focused Recruiting nowParaesophageal hernia can cause significant clinical symptoms, including reflux, chest pain, nausea, regurgitation, and even life threatening conditions such as bowel obstruction, and gastric volvulus. Repair of a paraesophageal hernia is associated with significant recurrence ra…
Sponsor: Corewell Health West • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Can a Pre-Surgery diet change help prostate cancer patients?
Knowledge-focused OngoingThis clinical trial studies the effects of a dietary intervention prior to surgery (neoadjuvant) in patients with intermediate risk prostate cancer. Changing your diet before surgery may help to improve overall health. Information from this study may help researchers better under…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
New eye scans could revolutionize how we see retinal disease
Knowledge-focused Recruiting nowThe objective of the study is to collect adaptive optics (AO) retinal images from human subjects with outer retinal diseases (diseases of the outer retina including photoreceptor, retinal pigment epithelium (RPE), basement membrane or choroidal pathologies) to develop new diagnos…
Sponsor: Food and Drug Administration (FDA) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Smart wire could reveal clot secrets during stroke treatment
Knowledge-focused CompletedThe purpose of this First-in-Human study is to evaluate the safety of using the Clotild® system to guide the endovascular thrombectomy (EVT) device to the clot location during EVT for the treatment of an acute ischemic stroke eligible to EVT, whatever the EVT device chosen. A sec…
Sponsor: Sensome • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Step counts may predict trouble during lung cancer therapy
Symptom relief Stopped earlyThis trial will examine if the monitoring of daily step counts during a course of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer will enable clinicians to deliver improved supportive care and reduce the rate of adverse events during the course of rad…
Sponsor: NRG Oncology • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
New drug shows promise in early trial for advanced cancers
Disease control CompletedThis is a Phase 1 study to assess the safety and clinical activity of RO7623066 alone and in combination in patients with advanced solid tumors.
Phase 1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Diabetes and aspirin: new study checks if the standard dose is enough
Knowledge-focused OngoingThis phase 1 study will include patients suffering from type 2 diabetes mellitus and will study their response to enteric coated aspirin at a dose of 80 mg per day for a 7-day period. The aims are to determine the feasibility of a phase 2 larger scale trial, and to characterize t…
Early phase 1 • Sponsor: Montreal Heart Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
Could a tiny aspirin dose plus a blood thinner be safer for heart patients?
Knowledge-focused CompletedThe trial is a pharmacodynamic study to determine the effect of a novel regimen of aspirin 20 mg BD plus rivaroxaban 2.5 mg BD on haemostasis, fibrin clot dynamics, inflammatory markers, platelet function and arachidonic acid metabolites when compared to standard regimens of aspi…
Phase 4 • Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Stomach cancer surgery combo trial fizzles: only 6 patients enrolled
Disease control Stopped earlySurgical resection of the primary tumour and treatment of the metastatic site in oligometastatic stage IV metastatic gastric adenocarcinoma enhances survival and improves quality of life with acceptable postoperative morbidity and mortality in a selected group of operable patient…
Phase 3 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New sepsis guidelines for pregnant women put to the test
Knowledge-focused CompletedDespite advances in the diagnosis and treatment of sepsis, the studies available in the literature report very high maternal and fetal/neonatal mortality and morbidity in cases of sepsis occurring during pregnancy or the puerperium. It is the third leading cause of maternal death…
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Can a simple arm band ease tennis elbow pain?
Symptom relief Recruiting nowThe study aims to evaluate the effectiveness of Blood Flow Restriction Training for the treatment of lateral elbow epicondylopathy.
Sponsor: Technical University of Munich • Aim: Symptom relief
Last updated Jun 26, 2026 17:26 UTC
-
Psoriatic arthritis drug showdown: which treatment do patients stick with?
Knowledge-focused OngoingThe purpose of this study is to evaluate treatment persistence with guselkumab and interleukin-17 inhibitor (IL-17i) initiated at enrollment into this study (PsABIOnd).
Sponsor: Janssen Pharmaceutica N.V., Belgium • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Zapping nerves with ultrasound: a new hope for heart failure?
Disease control CompletedThe purpose is to evaluate the renal denervation system (PRDS-001) for controlling sympathetic nerve over-activation in patients with heart failure, and for its safety in such patients.
Sponsor: Otsuka Medical Devices Co., Ltd. Japan • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC